Showing Results for
- Academic Journals (154)
Search Results
- 154
Academic Journals
- 154
- Search Terms:
- 1From: Cardiovascular Diabetology. (Vol. 11) Peer-ReviewedBackground Generalized arterial alterations, such as endothelial dysfunction, medial matrix accumulations, and calcifications are associated with type 2 diabetes (T2D). These changes may render the vessel wall more...
- 2From: Cardiovascular Diabetology. (Vol. 11) Peer-ReviewedBackground The prognostic benefits of beta-blockers (BB) in patients with systolic heart failure (SHF) are known but despite this, in patients with diabetes they are underutilized. The aim of this study was to assess...
- 3From: Cardiovascular Diabetology. (Vol. 11, Issue 1) Peer-ReviewedBackground Increased low-density lipoprotein cholesterol (LDL) concentration is associated with increased risk of coronary heart disease (CHD) but a substantial risk of cardiovascular disease often remains after LDL...
- 4From: Cardiovascular Diabetology. (Vol. 11, Issue 1) Peer-ReviewedBackground Many patients who survive a myocardial infarction (MI) remain at risk of sudden cardiac death despite revascularization and optimal medical treatment. We used the modified moving average (MMA) method to...
- 5From: Cardiovascular Diabetology. (Vol. 11, Issue 1) Peer-ReviewedBackground Vitamin D deficiency has been associated with impaired human insulin action, suggesting a role in the pathogenesis of diabetes mellitus type 2 (T2DM). In this prospective interventional study we...
- 6From: Cardiovascular Diabetology. (Vol. 11, Issue 1) Peer-ReviewedIt has been reported previously that diabetic cardiomyopathy can be inhibited or reverted with chronic zinc supplementation. In the current study, we hypothesized that total cardiac calcium and zinc content is altered...
- 7From: Cardiovascular Diabetology. (Vol. 11, Issue 1) Peer-ReviewedBackground The aim of this study was to investigate whether obestatin (OB), a peptide mediator encoded by the ghrelin gene exerting a protective effect in ischemic reperfused heart, is able to reduce cardiac...
- 8From: Cardiovascular Diabetology. (Vol. 11, Issue 1) Peer-ReviewedBackground Although the Fat Mass and Obesity (FTO) and Melanocortin-4 Receptor (MC4R) genes have been consistently associated with obesity risk, the association between the obesity-risk alleles with type 2 diabetes...
- 9From: Cardiovascular Diabetology. (Vol. 11) Peer-ReviewedDiabetes mellitus currently affects more than 170 million individuals worldwide and is expected to afflict another 200 million individuals in the next 30 years. Complications of diabetes as a result of oxidant stress...
- 10From: Cardiovascular Diabetology. (Vol. 11, Issue 1) Peer-ReviewedBackground The incidence of cardiac events is higher in patients with diabetes than in people without diabetes. The Coronary Atherosclerosis Study Measuring Effects of Rosuvastatin Using Intravascular Ultrasound in...
- 11From: Cardiovascular Diabetology. (Vol. 11, Issue 1) Peer-ReviewedBackground Health utility (HU) measures are used as overall measures of quality of life and to determine quality adjusted life years (QALYs) in economic analyses. We compared baseline values of three HUs including...
- 12From: Cardiovascular Diabetology. (Vol. 11, Issue 1) Peer-ReviewedObjective To assess the efficacy and safety of adding liraglutide to established insulin therapy in poorly controlled Chinese subjects with type 2 diabetes and abdominal obesity compared with increasing insulin dose....
- 13From: Cardiovascular Diabetology. (Vol. 11, Issue 1) Peer-ReviewedBackground Low serum amylase is likely to be associated with obesity and metabolic abnormalities, which are often accompanied by impaired insulin action. However, it is unclear whether low serum amylase is associated...
- 14From: Cardiovascular Diabetology. (Vol. 11, Issue 1) Peer-ReviewedBackground The presence of diabetes mellitus poses a challenge in the treatment of patients with acute myocardial infarction (AMI). We aimed to evaluate the sex-specific outcomes of diabetic and non-diabetic patients...
- 15From: Cardiovascular Diabetology. (Vol. 11, Issue 1) Peer-ReviewedBackground Diabetes remains a significant risk factor for restenosis/thrombosis following stenting. Although vascular healing responses following drug-eluting stent (DES) treatment have been characterized previously...
- 16From: Cardiovascular Diabetology. (Vol. 11, Issue 1) Peer-ReviewedBackground It has been suggested that the antioxidant properties of olmesartan (OLM), an angiotensin II type 1 receptor (AT.sub.1R) blocker, contribute to renal protection rather than blood pressure lowering effects...
- 17From: Cardiovascular Diabetology. (Vol. 11, Issue 1) Peer-ReviewedBackground In patients with type 1 diabetes mellitus (T1DM), cardiovascular events are more common, and the outcome following a myocardial infarction is worse than in nondiabetic subjects. Ischemic or pharmacological...
- 18From: Cardiovascular Diabetology. (Vol. 11, Issue 1) Peer-ReviewedBackground There is overwhelming evidence that dietary supplementation with n-3 polyunsaturated fatty acids (PUFAs), mainly EPA (C20:5n-3) and DHA (C22:6n-3), has cardiovascular protective effects on patients with...
- 19From: Cardiovascular Diabetology. (Vol. 11) Peer-ReviewedBackground This study investigated the cardiovascular (CV) safety profile of the dipeptidyl peptidase (DPP)-4 inhibitor linagliptin versus comparator treatments. Methods This was a pre-specified meta-analysis...
- 20From: Cardiovascular Diabetology. (Vol. 11, Issue 1) Peer-ReviewedBackground Calcium (Ca2+) handling proteins are known to play a pivotal role in the pathophysiology of cardiomyopathy. However little is known about early changes in the diabetic heart and the impact of insulin...